CHIEF MEDICAL EDITOR'S PAGE
By John R. Laird, Jr, MD with Michael R. Jaff, DO, FACP, FACC, FAHA
FEATURED TECHNOLOGYSponsored by Cardiva Medical, Inc.
Vascular closure devices can provide reliable and safe hemostasis at the arteriotomy site.
By Klaus Tiroch, MD, PhD, and Bernadette Longo, PhD
Two case reports detailing the use of the Viabahn endoprosthesis with heparin bioactive surface.
By Donald T. Baril, MD; Luke K. Marone, MD; and Mark H. Wholey, MD
VESSEL UPDATE: THORACIC AORTA
Insights shared at the 2007 Cleveland Clinic Stent Summit.
By Robert G. Whirley, PhD; Mike Nilson, BS; Catherine Szyman, MBA; Matthew S. Waninger, PhD; and Roy K. Greenberg, MD
A hybrid embolization technique involving occlusion coils and alcohol sclerosis.
By Michel K. Barsoum, MB, ChB; Thom W. Rooke, MD; and Haraldur Bjarnason, MD
Exercise and claudication pharmacotherapies as the foundation to redefine conservative care.
By Mudassar Ahmed, MD; Sara Murray, MD; and Alan T. Hirsch, MD
Optimal medical management.
By James A.M. Smith, DO
An editorial on what recent clinical trials have shown us about new antiplatelet agents.
By Bruce H. Gray, DO
Brian H. Annex, MD, a pioneer in angiogenesis research, discusses the current state of this investigative field, methods for delivery of agents, and areas of ongoing research, including a very recent genetic study in the area of peripheral arterial disease.
Leading researcher Douglas W. Losordo, MD, discusses the recent progress and future directions of this promising therapy.
By Douglas W. Losordo, MD
Endovascular Today interviews Giorgio M. Biasi, MD, President of the ISVS, who discusses the worldwide mission of the society and the state of vascular surgery.
An expert on renal artery therapy discusses when intervention is appropriate, the best methods for diagnosis, and some of the shortcomings of prospective, randomized studies of renal therapies.